Sort   by:  
 Page size 
ProteomicsStructural and Functional Glycosylation of the Abdala COVID-19 Vaccine
Abdala is a COVID-19 vaccine produced in Pichia pastoris and is based on the receptor-binding domain (RBD) of the SARS-CoV-2 spike. Abdala is currently approved for use in multiple countries with clinical trials confirming its safety and efficacy in preventing severe illness and death. Although P. p...
ORGANISM(S): Homo sapiens (Human) 
2025-05-07 | PXD058644 | Pride
Glycosylation Covid Sars Abdala 
UnknownStructural and Functional Glycosylation of the Abdala COVID-19 Vaccine.
Not available
S-EPMC11758712 | biostudies-literature
UnknownEvaluation of the Abdala Vaccine: Antibody and Cellular Response to the RBD Domain of SARS-CoV-2.
Not available
S-EPMC10748004 | biostudies-literature
UnknownA phase 3, randomised, double-blind, placebo-controlled clinical trial evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine in adults (ABDALA-3 study).
Not available
S-EPMC10160525 | biostudies-literature
UnknownSafety and Immunogenicity of the Intranasal Vaccine Candidate Mambisa and the Intramuscular Vaccine Abdala Used as Booster Doses for COVID-19 Convalescents: A Randomized Phase 1-2 Clinical Trial.
Not available
S-EPMC11435458 | biostudies-literature
UnknownCuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort study.
Not available
S-EPMC9507841 | biostudies-literature
UnknownImmunogenicity and safety assessment of a SARS-CoV-2 recombinant spike RBD protein vaccine (Abdala) in paediatric ages 3-18 years old: a double-blinded, multicentre, randomised, phase 1/2 clinical trial (ISMAELILLO study).
Not available
S-EPMC10462868 | biostudies-literature
ProteomicsAntioxidant, Immunomodulatory and Potential Anticancer Capacity of Polysaccharides (Glucans) from Euglena gracilis G.A. Klebs
The present study was carried out to determine the bioactivity of polysaccharides extracted from Euglena gracilis (EgPs). These were characterized by FT-IR and GC-MS. Cytotoxicity analyses (MTT) were performed on healthy human gingival fibroblast cell lines (HGF-1), obtaining an IC50 of 228.66 µg mL...
ORGANISM(S): Homo sapiens (Human) 
2022-12-21 | PXD029076 | Pride
Tmt-2plex. Sulfated polysaccharides Anticancer capacity Nutraceuticals Euglena gracilis Immunomodulatory capacity Antioxidant activity 
ProteomicsImmunomodulatory, antioxidant, and potential anticancer activity of the polysaccharides of the fungus Fomitiporia chilensis
Fomitiporia species have aroused the interest of numerous investigations that reveal their biological activity and medicinal potential. The present investigation shows the antioxi-dant, anticancer, and immunomodulatory activity of acidic polysaccharides obtained from the fungus Fomitiporia chilensis...
ORGANISM(S): Homo sapiens (Human) 
2024-10-17 | PXD048361 | Pride
Fomitiporia chilensis Hgf-1 cells Uhplc-hrms Polysaccharides 
UnknownSafety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study).
Not available
S-EPMC8994669 | biostudies-literature
Sort   by:  
 Page size